DeenaMary AtiehGrahamMD

Oncology • Hackensack, NJ

Breast Cancer, Gynecologic Cancer, Hematologic Oncology

John Theurer Cancer Center

Join to view full profile

Dr. Graham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Graham's full profile

Already have an account?

Office
92 2nd St
Hackensack, NJ 07601
Phone+1 551-996-5811

Fax+1 551-996-0577

Summary

As a breast and gynecological medical oncologist at John Theurer Cancer Center, I am conducting research with our NCI Cancer Designation partners to determine the effect of a breast cancer diagnosis and therapies on patient cognition. I am also involved in research that has resulted in certain breast cancer patients being able to avoid chemotherapy, and in the use of liquid biopsies to detect recurrences of breast cancer.

Deena Graham, M.D., treats women with breast and gynecological cancers

Dr. Deena Graham, medical oncologist at John Theurer Cancer Center, treats women with breast and gynecological cancers. Dr. Graham and her team conduct rese...

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2003 - 2006
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2000 - 2003
Boston University School of MedicineClass of 2000

Certifications & Licensure

NY State Medical License 2001 - 2026
NJ State Medical License 2006 - 2025
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel Start of enrollment: 2014 Jul 01
Withdrawn
Phase 1
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer Start of enrollment: 2015 Aug 24
Completed
Phase 3
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer Start of enrollment: 2016 Jan 28
Completed
Phase 2
Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Start of enrollment: 2017 Jan 31
Completed
Phase 2
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer Start of enrollment: 2017 Jun 21
Active, not recruiting
Phase 3
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers Start of enrollment: 2017 Feb 28
Terminated
Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer Start of enrollment: 2017 Aug 27
Recruiting
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) Start of enrollment: 2022 Dec 27
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

2 citations
An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Ca...
Danielle B Tometich, Catherine E Mosher, Melissa Cyders, Brenna C McDonald, Andrew J Saykin
Annals of Behavioral Medicine. 2023-04-05
53 citations
Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.
Kelly E. Rentscher, Xingtao Zhou, Brent J. Small, Harvey J. Cohen, Asma A. Dilawari
Cancer. 2021-06-23
7 citations
Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65.
Suzanne C. O'Neill, Claudine Isaacs, Filipa Lynce, Deena Graham, Calvin Chao
Breast Cancer Research. 2017-03-31

Press Mentions

Experts Lower Recommended Age for Mammograms from 50 to 40May 9th, 2023
Health Headlines: Role of Inflammation in Memory Problems for Cancer PatientsMarch 1st, 2023
Woman’s Best FriendMarch 15th, 2021